PDL BioPharma, Inc. Debt Conversion, Converted Instrument, Amount
PDL BioPharma, Inc. reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2013-03-01
- PDL BioPharma, Inc. debt conversion, converted instrument, amount for fiscal 2012 was $0.00.
- PDL BioPharma, Inc. debt conversion, converted instrument, amount for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- PDL BioPharma, Inc. debt conversion, converted instrument, amount for fiscal 2010 was $111.68M.
| Period end | Debt Conversion, Converted Instrument, Amount 10 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-01 | |
| 2011-12-31 | $0.00 10-K · filed 2013-03-01 | |
| 2010-12-31 | $111.68M 10-K · filed 2013-03-01 | |
| 2010-11-01 | $92.00M 10-K · filed 2012-02-23 |